Schizophrenia Clinical Trials

Showing 541-560 of 1,356 trials

Cognitive Remediation for Schizophrenia

NCT00295048

The purpose of this study is to evaluate the efficacy of an innovative, computer driven cognitive rehabilitation program for individuals with schizophrenia and related disorders.

Schizophrenia

University of Maryland, Baltimore50 participantsStarted Nov 2004

Baltimore, Maryland, United States • Baltimore, Maryland, United States • Catonsville, Maryland, United States

COMPLETEDPhase 3

A Phase 3, Long-term Safety and Tolerability Study of ALKS 3831 in Adults With Schizophrenia

NCT02873208

The primary objective of this study is to evaluate the long-term safety and tolerability of ALKS 3831 in subjects with schizophrenia.

Schizophrenia

Alkermes, Inc.266 participantsStarted Aug 2016

Little Rock, Arkansas, United States • Springdale, Arkansas, United States • Anaheim, California, United States +42 more locations

Cognitive Remediation for Schizophrenia

A Phase 3, Long-term Safety and Tolerability Study of ALKS 3831 in Adults With Schizophrenia

Related Searches

Cannabis and Schizophrenia: Self-Medication and Agonist Treatment

Safety, Tolerability, Pharmacokinetics and Efficacy of 180 mg Subcutaneous Risperidone From 6 mg Oral Risperidone

A Study to Evaluate ABT-126 for the Treatment of Cognitive Deficits in Schizophrenia

Study of m-RESIST, an m-Health Program for Treatment-resistant Schizophrenia

Motivational Interviewing in Patients With Schizophrenia

Adjunctive SPD489 to Antipsychotic Medication in Clinically Stable Adults With Persistent Predominant Negative Symptoms of Schizophrenia

Long-term Safety of SPD489 When Added to Stable Doses of Antipsychotic Medications in Clinically Stable Adults With Negative Symptoms of Schizophrenia

Efficacy, Safety, and Tolerability of SPD489 in Adults With Schizophrenia and Predominant Negative Symptoms

Influence of rTMS on Symptoms and Cognitive Function in Patients With Psychiatric Disorders

SPD489 as Adjunctive Treatment in Adults With Negative Symptoms of Schizophrenia

Assess the Safety and Pharmacokinetics of Ascending, Multiple Oral Doses of SPD489 in Adults With Schizophrenia

Effectiveness of Trauma Therapy in Patients With PTSD and Comorbid Psychotic Disorder

Study to Determine the Safety, Tolerability, and Efficacy of Evenamide in Patients With Chronic Schizophrenia

Transcranial Magnetic Stimulation (TMS) for Motor Symptoms in Psychiatric Disorders

RCT of tDCS Combined With Cognitive Training in Schizophrenia

Familial Schizophrenia and Spectrum Personality Disorders

Brain Circuits in Schizophrenia and Smoking

Bio-equivalence Study Between SAPHRIS and Asenapine